CORRECTION article
Front. Vet. Sci.
Sec. Veterinary Pharmacology and Toxicology
Volume 12 - 2025 | doi: 10.3389/fvets.2025.1687939
Correction: Clinical Evaluation of a Novel Fixed-Dose Combination Tablet (ForteGold) Versus Compounded Powdered Medications in Dogs with Myxomatous Mitral Valve Disease: A Randomized, Double-Blind Study
Provisionally accepted
- Changbaig Hyun amimal heart research institute, Dongtan, Republic of Korea
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
The original version of this article has been updated. In the published article, there was a mistake in the Funding statement. The funding statement for the Key Development Project of the Department of Science and Technology was displayed as "2015CBd051". The correct statement is "Key Development Project of Department of Science and Technology (2015C03Bd051).'' Correction: Clinical Evaluation of a Novel Fixed-Dose Combination Tablet (ForteGold) Versus Compounded Powdered Medications in Dogs with Myxomatous Mitral Valve Disease: A Randomized, Double-Blind Study Article title The title of this article was erroneously given as: Clinical Evaluation of a Novel Fixed-Dose Combination Tablet (Sentorphil® ForteGold) Versus Compounded Powdered Medications in Dogs with Myxomatous Mitral Valve Disease: A Randomized, Double-Blind Study. The correct title of the article is Clinical Evaluation of a Novel Fixed-Dose Combination Tablet (Sentorpil® ForteGold) Versus Compounded Powdered Medications in Dogs with Myxomatous Mitral Valve Disease: A Randomized, Double-Blind Study. Abstract Adding/removing text In the abstract, [Sentorphil® ]. This has been corrected to read: Sentorpil® Text correction Adding/removing text Can you change "Sentorphil® " to " Sentorpil® " in the whole manuscript.
Keywords: 1, 11, 1111, 11111, 111111
Received: 18 Aug 2025; Accepted: 26 Aug 2025.
Copyright: © 2025 Hyun. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Changbaig Hyun, Changbaig Hyun amimal heart research institute, Dongtan, Republic of Korea
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.